GETI.B

210.8

-0.71%↓

CAMX

586

-1.35%↓

BIOAB

310.2

-1.52%↓

EKTA.B

+0.27%↑

AMBEA

138.5

-1.07%↓

GETI.B

210.8

-0.71%↓

CAMX

586

-1.35%↓

BIOAB

310.2

-1.52%↓

EKTA.B

+0.27%↑

AMBEA

138.5

-1.07%↓

GETI.B

210.8

-0.71%↓

CAMX

586

-1.35%↓

BIOAB

310.2

-1.52%↓

EKTA.B

+0.27%↑

AMBEA

138.5

-1.07%↓

GETI.B

210.8

-0.71%↓

CAMX

586

-1.35%↓

BIOAB

310.2

-1.52%↓

EKTA.B

+0.27%↑

AMBEA

138.5

-1.07%↓

GETI.B

210.8

-0.71%↓

CAMX

586

-1.35%↓

BIOAB

310.2

-1.52%↓

EKTA.B

+0.27%↑

AMBEA

138.5

-1.07%↓

Home・Akciju saraksts・Vitrolife AB

V
Vitrolife AB

Atvērts

130.9 -1.13

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

129

Max

135.2

Galvenie mērījumi
By Trading Economics
Ienākumi	-30M 102M
Pārdošana	-36M 835M
P/E Sektora vidējais	41.539 76.798
EPS	0.753
Dividenžu ienesīgums	0.79
Peļņas marža	12.216
Darbinieki	1,100
EBITDA	118M 255M

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	0.79% 2.37%
Nākamie ieņēmumi	2026. g. 3. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-1.5B 18B
Iepriekšējā atvēršanas cena	132.03
Iepriekšējā slēgšanas cena	130.9

Vitrolife AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. dec. 23:50 UTC

Karstas akcijas

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

2025. g. 17. dec. 23:20 UTC

Peļņas

Correction to Micron Logs Sales Jump Article

2025. g. 17. dec. 23:07 UTC

Peļņas

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

2025. g. 17. dec. 21:37 UTC

Peļņas

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

2025. g. 17. dec. 23:53 UTC

Tirgus saruna

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

2025. g. 17. dec. 23:43 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

2025. g. 17. dec. 23:06 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

2025. g. 17. dec. 23:05 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

2025. g. 17. dec. 23:04 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

2025. g. 17. dec. 23:03 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

2025. g. 17. dec. 23:02 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

2025. g. 17. dec. 22:59 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

2025. g. 17. dec. 22:57 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

2025. g. 17. dec. 22:56 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

2025. g. 17. dec. 22:55 UTC

Iegādes, apvienošanās, pārņemšana

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

2025. g. 17. dec. 22:49 UTC

Tirgus saruna

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

2025. g. 17. dec. 21:58 UTC

Peļņas

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

2025. g. 17. dec. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2025. g. 17. dec. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 17. dec. 21:46 UTC

Peļņas

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

2025. g. 17. dec. 21:20 UTC

Peļņas

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

2025. g. 17. dec. 21:10 UTC

Peļņas

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

2025. g. 17. dec. 21:05 UTC

Peļņas

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

2025. g. 17. dec. 21:04 UTC

Peļņas

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

2025. g. 17. dec. 21:04 UTC

Peļņas

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

2025. g. 17. dec. 21:03 UTC

Peļņas

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

2025. g. 17. dec. 21:03 UTC

Peļņas

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

2025. g. 17. dec. 21:03 UTC

Peļņas

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

2025. g. 17. dec. 21:02 UTC

Peļņas

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

2025. g. 17. dec. 21:01 UTC

Peļņas

Micron Technology 1Q Rev $13.64B >MU

Salīdzinājums

Cenas izmaiņa

Vitrolife AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.